This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
Contracting with the Federal Government is not like a business deal between two companies or a contr...
This course will provide a detailed overview of the Medicare Secondary Payer act as well as provide ...
Artificial intelligence is already reshaping legal practice, from research and drafting to litigatio...
This program will address some of the most common intellectual property (IP) issues that arise in co...
This companion program to Part 1 goes deeper into the rhetorical power of Shakespeare, emphasizing h...
This advanced CLE dives into complex GAAP topics relevant to attorneys advising corporate, regulator...
This program examines listening as an active, strategic trial advocacy skill rather than a passive c...
In “Choosing the Right Business Entity,” I will walk through the issues that matter most...
This program explores listening as a foundational yet under-taught lawyering skill that directly imp...
Explore the transformative potential of generative AI in modern litigation. “Generative AI for...